Alignment Healthcare (ALHC) director receives 13,096 restricted stock units in equity grant

Rhea-AI Filing Summary

McClellan Mark B. reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. director Mark B. McClellan received an equity award of 13,096 restricted stock units of Common Stock. These units were granted at no cash cost and will vest on the one-year anniversary of the grant date, provided he continues serving on the Board of Directors. After this grant, he holds 370,531 shares directly, reflecting routine, compensation-related equity alignment with shareholders rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McClellan Mark B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,096	$0.00	--

Holdings After Transaction: Common Stock — 370,531 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McClellan Mark B.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		13,096(1)	A	$0	370,531	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Mark B. McClellan	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) director Mark B. McClellan report?

Mark B. McClellan reported receiving 13,096 restricted stock units of Alignment Healthcare Common Stock as an equity award. The units were granted at no cash cost and represent compensation for his Board service, not an open-market share purchase or sale.

How many Alignment Healthcare (ALHC) shares does Mark B. McClellan hold after this Form 4?

Following this equity award, Mark B. McClellan holds 370,531 shares of Alignment Healthcare Common Stock directly. This total includes the newly granted restricted stock units and reflects his updated ownership position as disclosed in the Form 4 filing.

When do Mark B. McClellan’s new Alignment Healthcare (ALHC) RSUs vest?

The 13,096 restricted stock units granted to Mark B. McClellan will fully vest on the one-year anniversary of the grant date. Vesting is contingent on his continued service as a member of the Board of Directors through that date.

Was Mark B. McClellan’s Alignment Healthcare (ALHC) Form 4 a market buy or sell?

The Form 4 reflects a grant of 13,096 restricted stock units as compensation, not a market buy or sell. The transaction is coded as an acquisition due to a grant or award, with a reported price per share of $0.0000.

What type of security did Mark B. McClellan receive from Alignment Healthcare (ALHC)?

Mark B. McClellan received restricted stock units, each representing a right to receive one share of Alignment Healthcare Common Stock. These RSUs are subject to a one-year vesting requirement tied to his continued service on the company’s Board of Directors.